N. Redinger

A new in vivo model to test anti-tuberculosis drugs using fluorescence imaging

U. Schaible, G. Bancroft, B. Robertson, 2012, The Journal of antimicrobial chemotherapy.

Strategies to Improve Vaccine Efficacy against Tuberculosis by Targeting Innate Immunity

U. Schaible, T. Dallenga, E. Patin, 2017, Front. Immunol..

In vitro and in vivo antitubercular activity of benzothiazinone-loaded human serum albumin nanocarriers designed for inhalation.

P. Imming, U. Schaible, B. Forbes, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Zirconyl Hydrogenphosphate Nanocontainers for Flexible Transport and Release of Lipophilic Cytostatics, Insecticides, and Antibiotics

U. Schepers, U. Schaible, C. Feldmann, 2019, Advanced Functional Materials.

Π-Π Interactions Stabilize PeptoMicelle-Based Formulations of Pretomanid Derivatives Leading to Promising Therapy Against Tuberculosis in Zebrafish and Mouse Models

A. M. Thompson, U. Schaible, R. Zentel, 2022, bioRxiv.

Mycobacterium tuberculosis Acetyltransferase Suppresses Oxidative Stress by Inducing Peroxisome Formation in Macrophages

U. Schaible, S. Ergün, B. Mishra, 2022, International journal of molecular sciences.

Amorphous Drug Nanoparticles for Inhalation Therapy of Multidrug-Resistant Tuberculosis.

U. Schaible, C. Feldmann, L. Dailey, 2023, ACS nano.

Π-Π interactions stabilize PeptoMicelle-based formulations of Pretomanid derivatives leading to promising therapy against tuberculosis in zebrafish and mouse models.

K. Koynov, Federico Fenaroli, A. Best, 2023, Journal of controlled release : official journal of the Controlled Release Society.

Transport of Lipophilic Anti‐Tuberculosis Drug Benzothiazone‐043 in Ca 3 (PO 4 ) 2 Nanocontainers

U. Schaible, C. Feldmann, N. Redinger, 2020, ChemNanoMat.